Trial Outcomes & Findings for Total Knee Replacement With Tourniquet or Aquamantys (NCT NCT04016285)
NCT ID: NCT04016285
Last Updated: 2024-04-18
Results Overview
The participant will sit in a seated position and a stabilizing strap will be placed around the bottom of the participant's shank and attached to a hand-held dynamometer. The participant will be asked to slowly kick the foot as hard as they can into the dynamometer pad (muscle testing hardware), and force will be measured. Increased measured force indicates greater quadriceps strength. Measurements will be recorded for both the operative extremity and the non-operative extremity, and the results will be expressed as a percentage of the mean strength measured in operative extremities compared to that measured in non-operative extremities for each study group.
COMPLETED
NA
73 participants
2 weeks
2024-04-18
Participant Flow
Patients at a large, academic hospital clinic seen in the practice of an early-career, fellowship-trained arthroplasty surgeon were screened for enrollment from 2019-2022. Patients between 18 and 85 years of age being scheduled for unilateral, elective primary TKA, and competent to provide informed consent and participate in the required testing and questionnaires at follow-up appointments were invited. Patients undergoing revision TKA or unicompartmental arthroplasty were excluded.
Participant milestones
| Measure |
Aquamantys
The Aquamantys bipolar sealer is a device used during surgery to help reduce bleeding in the joint. The system uses radiofrequency energy and sterile saline (salt water) to close small blood vessels in the knee to help reduce bleeding.
Subjects in this arm received total knee arthroplasty with the use of the Aquamantys bipolar sealer to aid in hemostasis.
|
Tourniquet
Pneumatic tourniquet use is a common practice for reducing bleeding during total knee arthroplasty
Subjects in this arm received total knee arthroplasty with the use of a pneumatic tourniquet to aid in hemostasis.
|
|---|---|---|
|
Overall Study
STARTED
|
36
|
37
|
|
Overall Study
COMPLETED
|
29
|
29
|
|
Overall Study
NOT COMPLETED
|
7
|
8
|
Reasons for withdrawal
| Measure |
Aquamantys
The Aquamantys bipolar sealer is a device used during surgery to help reduce bleeding in the joint. The system uses radiofrequency energy and sterile saline (salt water) to close small blood vessels in the knee to help reduce bleeding.
Subjects in this arm received total knee arthroplasty with the use of the Aquamantys bipolar sealer to aid in hemostasis.
|
Tourniquet
Pneumatic tourniquet use is a common practice for reducing bleeding during total knee arthroplasty
Subjects in this arm received total knee arthroplasty with the use of a pneumatic tourniquet to aid in hemostasis.
|
|---|---|---|
|
Overall Study
Did not progress to surgery
|
2
|
5
|
|
Overall Study
Failed to collect outcome data
|
5
|
3
|
Baseline Characteristics
Total Knee Replacement With Tourniquet or Aquamantys
Baseline characteristics by cohort
| Measure |
Aquamantys
n=34 Participants
The Aquamantys bipolar sealer is a device used during surgery to help reduce bleeding in the joint. The system uses radiofrequency energy and sterile saline (salt water) to close small blood vessels in the knee to help reduce bleeding.
Subjects in this arm received total knee arthroplasty with the use of the Aquamantys bipolar sealer to aid in hemostasis.
|
Tourniquet
n=32 Participants
Pneumatic tourniquet use is a common practice for reducing bleeding during total knee arthroplasty
Subjects in this arm received total knee arthroplasty with the use of a pneumatic tourniquet to aid in hemostasis.
|
Total
n=66 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Customized
44-54 years
|
4 Participants
n=99 Participants
|
7 Participants
n=107 Participants
|
11 Participants
n=206 Participants
|
|
Age, Customized
55-64 years
|
17 Participants
n=99 Participants
|
13 Participants
n=107 Participants
|
30 Participants
n=206 Participants
|
|
Age, Customized
65-74 years
|
9 Participants
n=99 Participants
|
9 Participants
n=107 Participants
|
18 Participants
n=206 Participants
|
|
Age, Customized
75+ years
|
4 Participants
n=99 Participants
|
3 Participants
n=107 Participants
|
7 Participants
n=206 Participants
|
|
Sex/Gender, Customized
Man
|
13 Participants
n=99 Participants
|
15 Participants
n=107 Participants
|
28 Participants
n=206 Participants
|
|
Sex/Gender, Customized
Woman
|
21 Participants
n=99 Participants
|
17 Participants
n=107 Participants
|
38 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
White, Non-Hispanic
|
25 Participants
n=99 Participants
|
30 Participants
n=107 Participants
|
55 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Black, Non-Hispanic
|
5 Participants
n=99 Participants
|
1 Participants
n=107 Participants
|
6 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Asian
|
1 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
1 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Hispanic
|
0 Participants
n=99 Participants
|
1 Participants
n=107 Participants
|
1 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Other
|
3 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
3 Participants
n=206 Participants
|
|
Body Mass Index, Categorical
<18.5 kg/m^2
|
1 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
1 Participants
n=206 Participants
|
|
Body Mass Index, Categorical
18.5-24.9 kg/m^2
|
3 Participants
n=99 Participants
|
2 Participants
n=107 Participants
|
5 Participants
n=206 Participants
|
|
Body Mass Index, Categorical
25-29.9 kg/m^2
|
17 Participants
n=99 Participants
|
18 Participants
n=107 Participants
|
35 Participants
n=206 Participants
|
|
Body Mass Index, Categorical
30-39.9 kg/m^2
|
6 Participants
n=99 Participants
|
5 Participants
n=107 Participants
|
11 Participants
n=206 Participants
|
|
Body Mass Index, Categorical
40+ kg/m^2
|
7 Participants
n=99 Participants
|
7 Participants
n=107 Participants
|
14 Participants
n=206 Participants
|
PRIMARY outcome
Timeframe: 2 weeksPopulation: The numbers of participants listed in this section do not match the overall number of participants listed as completing the study. This is due to lapses in data collection procedures that were brought on by high rates of research staff turnover during the COVID-19 pandemic. The numbers here reflect the number of participants in each group for whom isometric quadriceps strength was collected at two weeks in both the operative extremity and the non-operative extremity.
The participant will sit in a seated position and a stabilizing strap will be placed around the bottom of the participant's shank and attached to a hand-held dynamometer. The participant will be asked to slowly kick the foot as hard as they can into the dynamometer pad (muscle testing hardware), and force will be measured. Increased measured force indicates greater quadriceps strength. Measurements will be recorded for both the operative extremity and the non-operative extremity, and the results will be expressed as a percentage of the mean strength measured in operative extremities compared to that measured in non-operative extremities for each study group.
Outcome measures
| Measure |
Aquamantys
n=28 Lower Extremities
The Aquamantys bipolar sealer is a device used during surgery to help reduce bleeding in the joint. The system uses radiofrequency energy and sterile saline (salt water) to close small blood vessels in the knee to help reduce bleeding.
Subjects in this arm received total knee arthroplasty with the use of the Aquamantys bipolar sealer to aid in hemostasis.
|
Tourniquet
n=26 Lower Extremities
Pneumatic tourniquet use is a common practice for reducing bleeding during total knee arthroplasty
Subjects in this arm received total knee arthroplasty with the use of a pneumatic tourniquet to aid in hemostasis.
|
|---|---|---|
|
Isometric Quadriceps Strength
|
11.58 Nm/kg
Standard Deviation 7.87
|
9.60 Nm/kg
Standard Deviation 3.33
|
SECONDARY outcome
Timeframe: Preoperative, 2 weeks, 6 weeks, 12 weeksPopulation: The difficulty encountered in retaining research staff, in addition to the constraints associated with the COVID-19 pandemic, led to inability to collect this data point.
Pain will be measured using the visual analog scale (VAS), which assess pain levels on a scale from 0-10. Lower numbers indicate less pain while higher numbers indicate more pain.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 2 weeks post-op, 6 weeks post-opPopulation: This number differs from that listed in the primary outcome as this was a passive, participant driven outcome measure as opposed to our primary outcome, which required the presence of research staff at clinic follow up. It was our original intention to collect this information at 12 weeks following surgery. However, the increased pressure to reduce in-person visits during the COVID-19 pandemic necessitated a temporary change in practice and made collecting this data at 12 weeks unfeasible.
Knee injury Osteoarthritis Outcome Score, Joint Replacement (KOOS,JR) patient-reported outcome score. The KOOS, JR contains 7 items from the original KOOS survey. Items are coded from 0 to 4, none to extreme respectively. KOOS, JR scores are reported here in a range from 0-28 with mean and standard deviation for each group at two and six weeks post-op. Higher scores represent better perceived knee function.
Outcome measures
| Measure |
Aquamantys
n=26 Participants
The Aquamantys bipolar sealer is a device used during surgery to help reduce bleeding in the joint. The system uses radiofrequency energy and sterile saline (salt water) to close small blood vessels in the knee to help reduce bleeding.
Subjects in this arm received total knee arthroplasty with the use of the Aquamantys bipolar sealer to aid in hemostasis.
|
Tourniquet
n=28 Participants
Pneumatic tourniquet use is a common practice for reducing bleeding during total knee arthroplasty
Subjects in this arm received total knee arthroplasty with the use of a pneumatic tourniquet to aid in hemostasis.
|
|---|---|---|
|
Knee Osteoarthritis (KOOS,JR)
Two Week KOOS, JR Score
|
13 Score on a scale
Standard Deviation 2.2
|
10 Score on a scale
Standard Deviation 1.4
|
|
Knee Osteoarthritis (KOOS,JR)
Six Week KOOS, JR Score
|
16 Score on a scale
Standard Deviation 2.1
|
17 Score on a scale
Standard Deviation 1.8
|
SECONDARY outcome
Timeframe: PreoperativePopulation: The difficulty encountered in retaining research staff, in addition to the constraints associated with the COVID-19 pandemic, led to inability to collect this data point.
The Veterans Rand-12 Mental Component Score will be used to quantify the impact of the participants emotional health on their daily activities. The VR-12 consists of 12 questions, is scored from 0-100 with lower scores indicating that emotional health has a more dramatic impact on the participant's daily life.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Preoperative, 2 weeks, 6 weeks, 12 weeksPopulation: The difficulty encountered in retaining research staff, in addition to the constraints associated with the COVID-19 pandemic, led to inability to collect this data point.
The knee function questionnaire is a study-specific questionnaire to assess knee problems that may affect everyday life. It consists of three questions: one about walking support, one about going up stairs and one about coming down stairs. Responses are categorical, and will be used to compare the proportion of patients in each group that can walk without a walker or cane, or navigate stairs without the use of upper body support. The knee function questionnaire is not a graded scale, but will be used to assess the proportion of each group that self-reports the ability to perform these 3 tasks at each of the study time points.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 6 weeks, 12 weeksPopulation: The difficulty encountered in retaining research staff, in addition to the constraints associated with the COVID-19 pandemic, led to inability to collect this data point.
This is a timed test used to measure mobility and function. Participants are positioned in a standard 16" office chair with their arms at their sides and back located against the back of the chair. Participants are instructed to stand and sit as quickly as possible 5 times. The test is timed using a stopwatch and the timer is stopped when the individual achieves a standing position on the 5th trial. Shorter times indicate better mobility and function.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Preoperative, 2 weeks, 6 weeks, 12 weeksPopulation: The difficulty encountered in retaining research staff, in addition to the constraints associated with the COVID-19 pandemic, led to inability to collect this data point.
Opioid use will be assessed with a single question with a binary response (either yes the participant is taking opioid medications or no they are not).
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 6 weeks and 12 weeksPopulation: The difficulty encountered in retaining research staff, in addition to the constraints associated with the COVID-19 pandemic, led to inability to collect this data point.
Strength will be assessed at multiple time points during the study. The participant will sit in a seated position and a stabilizing strap will be placed around the bottom of the participant's shank and attached to a hand-held dynamometer. The participant will be asked to slowly kick the foot as hard as they can into the dynamometer pad (muscle testing hardware) placed on the anterior aspect of the participant's distal tibia. One practice trial followed by 3 actual trials will be performed. The participant will receive a 30-second rest in between each trial and a 1-minute rest in between legs for each test to prevent fatigue. Increased measured force indicates greater quadriceps strength.
Outcome measures
Outcome data not reported
Adverse Events
Aquamantys
Tourniquet
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Stephen Duncan
University of Kentucky Department of Orthopaedic Surgery & Sports Medicine
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place